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AbstrACt
Objectives To assess the prevalence of major obstetric 
haemorrhage managed with peripartum hysterectomy 
and/or interventional radiology (IR) in Belgium. To describe 
women characteristics, the circumstances in which the 
interventions took place, the management of the obstetric 
haemorrhage, the outcome and additional morbidity of 
these women.
Design Nationwide population-based prospective cohort 
study.
setting Emergency obstetric care. Participation of 97% of 
maternities covering 98.6% of deliveries in Belgium.
Participants All women who underwent peripartum 
hysterectomy and/or IR procedures in Belgium between 
January 2012 and December 2013.
results We obtained data on 166 women who underwent 
peripartum hysterectomy (n=84) and/or IR procedures 
(n=102), corresponding to 1 in 3030 women undergoing 
a peripartum hysterectomy and another 1 in 3030 women 
being managed by IR, thereby preserving the uterus. 
Seventeen women underwent hysterectomy following IR 
and three women needed further IR despite hysterectomy. 
Abnormal placentation and/or uterine atony were the 
reported causes of haemorrhage in 83.7%. Abnormally 
invasive placenta was not detected antenatally in 34% 
of cases. The interventions were planned in 15 women. 
Three women were transferred antenatally and 17 women 
postnatally to a hospital with emergency IR service. 
Urgent peripartum hysterectomy was averted in 72% 
of the women who were transferred, with no significant 
difference in need for transfusion. IR procedures were 
able to stop the bleeding in 87.8% of the attempts. 
Disseminated intravascular coagulation secondary to 
major haemorrhage was reported in 32 women (19%).
Conclusion The prevalence in Belgium of major obstetric 
haemorrhage requiring peripartum hysterectomy and/
or IR is estimated at 6.6 (95% CI 5.7 to 7.7) per 10 000 
deliveries. Increased clinician awareness of the risk 
factors of abnormal placentation could further improve 
the management and outcome of major obstetric 
haemorrhage. A case-by-case in-depth analysis is 
necessary to reveal whether the hysterectomies and 
arterial embolisations performed in this study were 
appropriate or preventable.
bACkgrOunD
Emergency peripartum hysterectomy is the 
single most dramatic procedure in modern 
obstetrics. The procedure is stressful and 
surgically challenging, inevitably causing 
additional maternal morbidity and, not 
least, infertility. It is listed by the WHO as an 
identification criterion for maternal near-
miss,1 a concept that, in view of the very 
low maternal mortality rates in developed 
country settings,2 was introduced as an analyt-
ical tool to address health system failures with 
the overall goal of improving obstetric care.3 
strengths and limitations of this study
 ► This is a nationwide study of Belgian maternities, 
with excellent participation and response rates 
(98.8%). The cases were collected on a monthly 
basis using the standard methodology of obstetric 
surveillance systems.
 ► This study describes how women with major 
obstetric haemorrhage were managed with 
peripartum hysterectomy and/or interventional 
radiology according to circumstances.
 ► The study lacks a perspective on the overall picture 
of postpartum haemorrhage in Belgium, namely the 
total number of women suffering severe postpartum 
haemorrhage, near-misses or death due to 
postpartum haemorrhage.
 ► The study lacks denominator data of the women with 
postpartum haemorrhage who were successfully 
managed with other second-line measures. 
Therefore we cannot draw conclusions on the failure 
rate of intrauterine balloon tamponade, haemostatic 
brace suturing and ligation of the uterine arteries.
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Substandard care in the management of major obstetric 
haemorrhage continues to be a critical cause of maternal 
death and severe maternal morbidity in developed coun-
tries.4 5 Every obstetric practitioner needs to be trained 
in the management of postpartum haemorrhage in order 
to guarantee an immediate response and a multidisci-
plinary team approach. Internationally recognised guide-
lines6–8 indicate that one or more second-line measures, 
including intrauterine (balloon) tamponade, haemostatic 
brace suturing, ligation of the uterine arteries and inter-
ventional radiology (IR), should be available in hospitals 
with delivery units and that obstetric practitioners should 
be familiar with these procedures. Notably, the early 
involvement of an experienced senior obstetrician, hence 
appropriate clinical judgement, can save lives: the timely 
decision to turn to a hysterectomy can avoid further blood 
loss, risk of disseminated intravascular coagulation (DIC), 
additional morbidity and finally death.6
While emergency peripartum hysterectomy serves as 
the ultimate response to major obstetric haemorrhage, 
resorting to IR procedures on the pathway towards hyster-
ectomy can be both life-saving and fertility-preserving. IR 
in this context basically involves intra-arterial balloon 
occlusion or arterial embolisation of the uterine or the 
internal iliac arteries. Research publications on the effec-
tiveness of IR procedures in obstetric settings reporting 
high success rates of 85%–95% are accumulating.9–12 
Success rates should be interpreted with caution, 
however, as they may be driven by ascertainment bias. IR 
is cautiously suggested in guidelines and recommenda-
tions6–8 13 14 describing its possible role in obstetric emer-
gency settings, but further evidence is awaited before firm 
recommendations can be made. Yet in the UK a national 
recommendation was made to provide a network of emer-
gency IR services available to all trusts with delivery units 
in response to a Healthcare Commission Investigation 
into maternal deaths.13 15
The aims of this study are to investigate the popula-
tion-based prevalence of peripartum hysterectomy and 
the indications to proceed to this intervention, likewise 
the prevalence of major obstetric haemorrhage managed 
with IR in Belgium. Furthermore, we aim to describe the 
characteristics of the women in Belgium who required 
these interventions in order to treat or prevent major 
obstetric haemorrhage, the circumstances in which the 
interventions took place, the management of the obstetric 
haemorrhage and the outcome and additional morbidity 
of these women.
MethOD
belgian Obstetric surveillance system
Peripartum hysterectomy and IR in Belgium were regis-
tered as part of a national reporting system for the 
study of rare obstetric complications. The methodology 
of the Belgian Obstetric Surveillance System (B.OSS) 
has been described previously.16 Briefly, an appointed 
contact person (obstetrician or senior midwife) in each 
participating maternity unit was invited by monthly 
mailing to report a selected number of rare obstetric 
complications that had occurred in the preceding 
month or, alternatively, to state that there was ‘nothing 
to report’. In the event of such a case being reported, 
the contact person was asked to complete an extensive 
data collection form. Confidentiality was guaranteed for 
mother, provider and hospital, and person-identifiable 
information was eliminated from data analysis. In cases of 
incomplete reporting, the appointed contact person was 
encouraged repeatedly by email and phone to provide 
the missing data, up to 6 months following the date of the 
original report.
The participation of 97% of Belgian maternity units 
(n=110/113) was obtained, covering 98.6% of deliveries 
(n=248 681) in the 2-year study period. Belgium has a rela-
tively large number of tertiary referral centres providing 
neonatal intensive care (n=19) along with a high concen-
tration of small-volume maternity units (more than half 
of all units) in which there are fewer than 1000 annual 
births. All tertiary referral centres, as well as some of the 
larger non-tertiary maternity services, have an emergency 
IR service. In answer to an enquiry of B.OSS contact 
persons, 40 maternity units (38%) declared they had an 
IR service available in the hospital, and a further seven 
units declared that they had an IR service available but 
not 24/7 or that they could call on vascular surgeons for 
similar procedures.
study period
The study was conducted between January 2012 and 
December 2013.
Case definition
B.OSS aimed to collect all cases of peripartum hysterec-
tomy and IR at any gestational age corresponding to the 
following definition: any woman giving birth to a fetus 
or infant and undergoing a hysterectomy and/or IR 
procedure in the same clinical episode. Most peripartum 
hysterectomies are emergency, life-saving interventions 
following vaginal or caesarean delivery, most commonly 
performed to manage major obstetric haemorrhage but 
occasionally because of a severe pelvic infection. Hyster-
ectomy in the first or second trimester, termed abor-
tion hysterectomy, is occasionally required to prevent or 
manage major obstetric haemorrhage resulting from an 
abnormally invasive placenta (AIP) or an ectopic preg-
nancy in the cornua, the cervix or a caesarean scar. A peri-
partum hysterectomy during caesarean delivery (CD), 
termed ‘caesarean hysterectomy’, can be performed elec-
tively following antenatal diagnosis of a severe AIP or a 
gynaecological cancer.
Failure of IR was defined as the need for urgent peri-
partum hysterectomy to control the haemorrhage.
registered variables
Data collection forms sought information on maternal 
characteristics, medical, surgical and obstetric history, 
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details of the index pregnancy, details of the delivery, the 
circumstances of the adverse event, its management, and 
the outcome for mother and neonate.
The cause of the obstetric haemorrhage was deduced 
from the clinical signs reported by the clinician and 
classified according to the 4T’s mnemonic: tonus, 
tissue, trauma and thrombin. These labels were taken 
to stand for the following characteristics: tonus: uterine 
atony; tissue: AIP, placenta praevia, combination of AIP 
and placenta praevia, placental remnants or retained 
placenta without AIP; trauma: uterine rupture, genital 
tract lacerations, bleeding caused by unintended inju-
ries during caesarean delivery or curettage (uncom-
plicated CDs were not included in this category); 
and thrombin: abnormal coagulation before onset of 
bleeding (DIC secondary to major haemorrhage was 
not included in this category). Cases where the cause of 
bleeding remained unclear or unknown were classified 
as ‘Other’.
registered variables of the background population
The Belgian perinatal registries — Studiecentrum 
voor Perinatale Epidemiologie (SPE) in Flanders,17 18 
and Centre d’Epidémiologie Périnatale in Brussels19 
and Wallonia20 — record data on a mandatory basis, 
covering nearly 100% of births in Belgium. A selected 
set of perinatal data are recorded by the obstetrician, 
midwife and neonatologist immediately after birth. 
Births are registered as such in cases of a live birth or 
in cases of a stillbirth at a birth weight of 500 g or more 
and/or after 22 completed weeks of gestation, although 
in Flanders (SPE) live births or stillbirths with a birth 
weight below 500 g, irrespective of gestational age, are 
not registered.
statistical analysis
The aim was to record all cases of peripartum hyster-
ectomy and arterial embolisation during a 2-year study 
period, meaning that no fixed sample size was set at 
start of the study. The prevalence of the obstetric events 
targeted was estimated using as denominator the total 
number of deliveries in Belgium in 2012 and 2013, 
corrected for the three hospitals that did not partici-
pate in B.OSS (n=248 681 women). Comparison of 
the distributions of sociodemographic and obstetric 
characteristics of reported cases relative to the back-
ground population as obtained from the Belgian peri-
natal registry (2012–2013) was pursued through use of 
ORs. ORs and accompanying 95% CI were calculated in 
univariate analysis, using weighted cases where appro-
priate. Unadjusted and adjusted ORs were calculated 
in order to compare patient and organisational char-
acteristics between interventions (hysterectomy vs IR) 
in univariate analysis and subsequently through the 
use of unconditional binary logistic regression models. 
Comparison between successful and failed IR cases was 
made only in crude analyses, as numbers of observations 
were too small to support logistic regression models. 
Non-parametric tests were used to compare distribu-
tions of outcomes between groups, specifically χ2 for 
categorical variables, and Kruskal-Wallis and Mann-
Whitney U tests for continuous variables. p Values of 
<0.05 were considered statistically significant. Data were 
analysed using the statistical software package IBM SPSS 
V.22.0 statistics.21
The Strengthening the Reporting of Observational 
Studies in Epidemiology guidelines for reporting obser-
vational studies were followed.
results
Prevalence
Data collection forms of 166 confirmed cases of peri-
partum hysterectomy and/or IR were retrieved and 
included in the analysis. Details of reported cases and 
completeness of data collection forms are presented in 
figure 1.
Overall, 84 women (50.6%) underwent a peripartum 
hysterectomy, corresponding to a prevalence of 3.3 per 
10 000 deliveries (95% CI 2.7 to 4.1). Of these, 17 women 
(10.2%) underwent a hysterectomy following a previous 
IR procedure. Eighty-two women (49.4%) were managed 
with IR only, corresponding to a prevalence of 3.3 per 
10 000 deliveries (95% CI 2.6 to 4.0). Three women 
(1.8%) needed IR because of persistent bleeding despite 
hysterectomy.
In 160 women the intervention occurred within 
24 hours of delivery. In eight women it occurred later 
Figure 1 Flow chart of case reporting and data collection.
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(from 24 hours to 6 weeks postpartum). The discrep-
ancy between the resultant sum of 168 and the 166 
figure above is because two of the data collection forms 
were not returned, one of these being the only case in 
this data set of a hysterectomy performed because of 
severe peritonitis. All other women underwent hyster-
ectomy and/or IR to treat or prevent major obstetric 
haemorrhage. The prevalence in Belgium of major 
obstetric haemorrhage requiring peripartum hysterec-
tomy and/or IR is estimated at 6.6 (95% CI 5.7 to 7.7) 
per 10 000 deliveries.
Patient characteristics
We compared the women included in this registry with 
all the women who gave birth in Belgium during the 
study period. Patient characteristics of the background 
population were derived from the Belgian perinatal regis-
tries. In univariate analysis the women who underwent 
peripartum hysterectomy and/or IR for major obstetric 
haemorrhage were significantly more likely compared 
with the background population to be older (≥35 years), 
to be multiparous (parity ≥3), to have given birth at a 
preterm gestational age, to have had a twin pregnancy, 
to have had a CD in a previous pregnancy, to have had a 
CD in the index pregnancy and to have conceived with 
artificial reproductive technology (table 1). Ten of these 
166 women were known to have a uterus myomatosus 
(6.0%) and 12 experienced haemorrhage in a previous 
pregnancy (7.2%).
Circumstances of the obstetric haemorrhage
IR service availability, antenatal and postnatal transfers, and urgent 
and planned interventions
The circumstances in which the interventions occurred 
in these 166 women are shown in figure 2. Three women 
were transferred antenatally to another hospital with 
emergency IR service availability, a total of 107 women 
gave birth in a maternity unit with this availability, while 
Table 1 Patient characteristics of women with (imminent) obstetric haemorrhage who underwent peripartum hysterectomy 
and/or IR compared with all women who gave birth in Belgium during the study period
Risk factor
Cases of H and/or IR
(n=166) n, %
Background population*
(n=252 272) n, %
Unadjusted OR† for H 
and/or IR (95% CI)
Maternal age ≥35 years 72 (43.4) 43 256 (17.1) 3.7 (2.7 to 5.0)**
BMI at booking ≥30 kg/m2 12 (7.2)¶ 29 453 (11.6) 0.7 (0.3 to 1.2)
Gestational age (weeks) Singletons ≥22 weeks
(n=144)
Singletons ≥22 weeks
(n=241 136)
  Extreme preterm (<28) 8 (5.4) 1221 (0.5) 7.4 (5.3 to 10.5)**
  Very preterm(28-32 weeks) 6 (4.0) 1474 (0.6)
  Late preterm(32-37 weeks) 37 (24.8) 13 798 (5.7)
  Term (>37) 93 (62.4) 224 643 (93.1) Reference
Parity ≥3 30 (18.0) 18 855 (7.4) 2.7 (1.8 to 4.1)**
Multiplets (twin) 13 (7.8) 4690 (1.8) 4.4 (2.5 to 7.9)**
Previous CD‡ 61 (36.7)¶ 27 007 (10.7) 4.8 (3.5 to 6.6)**
TOLAC (≥22 weeks) 14/57 (24.5) 12 754/27 007 (47.2) 0.3 (0.1 to 0.66)**
Delivery mode (≥22 weeks)
  CD§ compared with VD 91/160 (56.8)¶ 54 369 (21.5) 4.8 (3.5 to 6.5)**
  CD before onset of labour compared with CD after 
onset of labour
66/91 (72.5) 28 586/54 369 (52.5) 2.3 (1.5 to 3.7)
  Assisted VD compared with spontaneous VD 10/69 (14.4) 23 100/198 444 (11.6) 1.3 (0.6 to 2.5)
ART (IVF/ICSI) 19 (11.4)¶ 9233 (3.7) 3.4 (2.1 to 5.4)**
Birth weight ≥4000 g 11 (6.6) 19 967 (7.8) 0.8 (0.4 to 1.5)
Reason for CD: bleeding (placenta praevia, AIP, abruptio placentae): n=15; placenta praevia/AIP not bleeding: n=29; maternal shock/cardiac 
arrest: n=1; Other: n=46.
*Data from the background population were retrieved from SPE reports (Flanders) and CEpiP reports (Brussels and Wallonia) from 2012 to 
2013.
†Unadjusted ORs (with 95% CI) for peripartum hysterectomy and/or IR calculated for the different risk factors: the odds (=probability of 
peripartum hysterectomy and/or IR occurring divided by the probability of H/IR not occurring) in the women having the risk factor, divided by 
the odds in the women not having the risk factor.
‡Women with CD as delivery mode: 17 with placenta praevia, 8 with AIP, and 23 with placenta praevia and AIP.
§Women with previous CD: 9 with placenta praevia, 9 with AIP, and 17 with placenta praevia and AIP.
¶Missing data in cases of hysterectomy and/or IR: BMI (n=27), previous CD (n=1), mode of delivery (n=1), ART (n=2), haemorrhage in previous 
pregnancy (n=5), uterus myomatosus (n=5).
**p<0.05.
AIP, abnormally invasive placenta; ART, artificial reproductive technologies; BMI, body mass index; CD, caesarean delivery; CEpiP; Centre 
d’Epidémiologie Périnatale; H, hysterectomy; ICSI, intracytoplasmic sperm injection; IR, interventional radiology; IVF, in vitro fertilisation; SPE, 
Studiecentrum voor Perinatale Epidemiologie; TOLAC, trial of labour after caesarean delivery; VD, vaginal delivery.
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20 gave birth in a unit where IR service is available but not 
24/7 or where obstetricians can call on vascular surgeons 
for IR procedures, and 39 in a unit with no IR service. 
To refer to these different circumstances below, we use 
the terms 24/7-IR unit, not 24/7-IR unit and non-IR unit, 
respectively.
Seventeen women were transferred postnatally to a 
24/7-IR unit and underwent an urgent IR procedure, 
including one woman for persistent bleeding despite 
hysterectomy and one woman for persistent bleeding 
despite planned intra-arterial balloon occlusion and arte-
rial embolisation by the vascular surgeons in the refer-
ring hospital. Three of the postnatally transferred women 
consecutively underwent an urgent hysterectomy for 
persistent bleeding despite arterial embolisation.
Of the three patients who were transferred antenatally, 
one underwent an urgent embolisation on arrival because 
of a bleeding placenta praevia, one was first planned for 
caesarean hysterectomy but then underwent this proce-
dure urgently because of a bleeding AIP before the fixed 
date, and one underwent a planned CD combined with 
a planned IR procedure because of AIP. Seven more 
women were transferred postnatally to the intensive care 
unit (ICU) of a tertiary referral centre.
Overall, intervention for imminent obstetric haemor-
rhage was planned in 15 women. The indication was AIP 
in 13 women and placenta praevia in 2 women.
Reported cause of the obstetric haemorrhage
Eighteen women (11%) presented with antepartum 
haemorrhage due to abnormal placentation (placenta 
praevia, AIP or both) or abruptio placentae (n=2). Four 
women (2%) started bleeding during termination of 
pregnancy (<24 weeks) due to a cervical pregnancy (n=1) 
or an AIP (n=3). One hundred and thirty-eight women 
(83%) presented with early postpartum haemorrhage 
(within 24 hours) and six (4%) with late postpartum 
haemorrhage (from 24 hours to 6 weeks).
The reported cause of the obstetric haemorrhage was 
uterine atony (n=91, 54.8%) or AIP (n=38, 22.8%) in the 
majority of women. In 54 women (32.5%) more than one 
cause was reported, with atony and abnormal placenta-
tion (AIP and/or placenta praevia) in 20 women (12%) 
as the most frequent combination. The cause of the 
(imminent) obstetric haemorrhage classified according 
to the 4T’s mnemonic is shown in figure 3.
Management of the obstetric haemorrhage
Hysterectomy was performed in all the cases of haem-
orrhage reported to be associated with uterine rupture 
(n=12) and in 73.7% of the cases associated with AIP 
(n=28/38). IR was able to stop the bleeding and avert 
the need for peripartum hysterectomy in the majority 
of cases of haemorrhage reported to be associated with 
genital tract lacerations (n=10/12, 83.3%), placental 
remnants or retention (n=17/26, 65.4%) and uterine 
atony (n=28/43, 65.1%).
Other measures that were attempted to manage the 
obstetric haemorrhage before or while proceeding to 
the hysterectomy or IR are listed in table 2. The first-line 
measures were the administration of uterotonic agents and 
bimanual uterine compression, second-line measures being 
intra-uterine (balloon) tamponade, haemostatic brace 
suturing (B-lynch or other) and ligation of the uterine or 
internal iliac arteries, besides blood transfusion and the 
administration of fresh frozen plasma (FFP), platelets or 
clotting factors. An intra-uterine balloon was inserted in 35 
women (21%), in 7 cases before transfer to another hospital 
with availability of an IR service. Brace suturing and arterial 
ligation were attempted in 6 and 4 women, respectively. In 
19 women (11.4%) no other measures were undertaken 
besides hysterectomy (n=13), IR (n=2) or hysterectomy 
Figure 2 Circumstances in which peripartum hysterectomy 
and interventional radiology occurred in 166 women.
Figure 3 Cause of obstetric haemorrhage according to the 
4T’s mnemonic.
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following IR (n=4). The reported cause of haemorrhage 
in these women was AIP (n=12), placenta praevia (n=2), 
uterine rupture (n=2), retained placenta (n=2) and in one 
case a late postpartum haemorrhage. The intervention 
was planned in five of these women. Eight of the 19 had 
minor haemorrhage and did not require transfusion, while 
three women undergoing urgent peripartum hysterectomy 
needed massive transfusion (defined as receiving eight or 
more units of red blood cells (RBCs)).
Management of AIP
The management of the (imminent) obstetric haem-
orrhage in the women with AIP (n=38) is illustrated in 
figure 4 (for details see online supplementary figure 1). 
Seventeen women (45%) were susceptible to AIP due to 
previous CD and placenta praevia in the index pregnancy, 
another seven women (18%) had placenta praevia in the 
index pregnancy and nine women (24%) had previous 
CD. In 25 women (65.7%) there was antenatal suspicion 
of the AIP, of whom 16 had placenta praevia and previous 
CD, 5 had placenta praevia and 4 had previous CD only. 
All women with antenatal suspicion of AIP were planned to 
undergo an elective CD in a maternity unit with IR service 
availability (24/7 n=20, not 24/7 n=5). This occurred in 21 
women, with 3 women having an emergency CD because 
of antepartum haemorrhage and 1 woman delivering vagi-
nally following acute onset of labour. Further preventive 
measures were undertaken in 13 women (31.5%): ante-
natal transfer to a centre with IR service availability (n=2), 
placement of intra-arterial catheters precaesarean delivery 
(n=12), planned caesarean hysterectomy (n=3) or planned 
hysterectomy at a later stage (n=2).
In 13 women (34%) there was no antenatal suspicion 
of the AIP. In retrospect, though, all of them had risk 
factors: one woman had placenta praevia and previous 
CD, four had placenta praevia, six had previous CD, one 
had previous myomectomy and adhesiolysis for Asherman 
Table 2 First-line and second-line measures in women undergoing hysterectomy (H) and/or interventional radiology (IR) 
according to the circumstances of the obstetric haemorrhage
Total n=166
n (%)
Planned H 
and/or IR, 
n=15
n (%)
Urgent H and/or IR, n=151
IR service 
24/7, n=98
n (%)
IR service not 
24/7, n=12
n (%)
No IR service, 
n=25
n (%)
Postnatal 
transfer, n=16*
n (%)
Cause of obstetric haemorrhage
  Abnormal placentation 56 (34) 15 (100) 29 (30)  5 (42) 5 (20) 2 (13)
  Atony only 43 (26)  — 29 (30) 5 (42) 7 (28) 2 (13)
  Uterine rupture   12 (7)  —  6 (6)  1 (8) 5 (20) —
  Miscellaneous† 55 (33)  — 34 (34)  1 (8) 8 (32) 12 (75)
First-line and second-line measure
  Uterotonics 134 (81) 10 (67) 81 (83) 10 (83) 19 (76) 15 (94)
  Oxytocin 123 (74) 10 (67) 73 (75)  9 (75) 18 (72) 13 (81)
  PG 109 (66)  5 (33) 64 (65) 17 (68) 8 (67) 15 (94)
  Misoprostol 61 (37)  1 (7) 34 (35)  6 (50) 10 (40) 10 (63)
  Carboprost 63 (39)  5 (33) 42 (43)  3 (25) 9 (25) 9 (56)
  Oversewing‡ 30 (18)  1 (7) 19 (20)  1 (8) 7 (28) 2 (13)
  (Bimanual) compression 64 (39)  3 (20) 36 (37)  5 (42) 9 (36) 11 (69)
  Balloon tamponade 35 (21)  2 (13) 21 (22)  2 (17) 3 (12) 7 (44)
  B-lynch or ligation   10 (6) —  5 (5)  1 (8) 4 (16) —
  Transfusion 139 (84)  7 (47) 85 (87) 12 (100) 21 (84) 15 (88)
  Massive transfusion§ 51 (31)  2 (13) 24 (24)  7 (58) 10 (40) 8 (50)
  Fresh frozen plasma 108 (65)  4 (27) 64 (65) 11 (92) 18 (72) 11 (69)
  Platelets 57 (34)  1 (7) 29 (30)  9 (75) 10 (40) 8 (50)
  Clotting factors¶ 23 (14)  —  8 (8)  5 (42) 7 (28) 3 (19)
*One woman was transferred postnatally for persistent bleeding due to abnormally invasive placenta despite planned IR in the referring 
hospital; she was included in the ‘planned’ group.
†Miscellaneous group: placental remnants or retention n=25, surgical trauma n=16, genital tract laceration n=11, intra-abdominal arterial 
bleeding n=4, coagulation disorders n=3, unknown n=6. The total number exceeds n=55 due to overlap in between cases.
‡Oversewing of the placental implantation site, bleeding points, tears or ruptures.
§Massive transfusion: transfusion of 8 or more units of red blood cells.
¶Clotting factors: fibrinogen, recombinant factor VIIa, prothrombin-proconvertin-Stuart factor-antihaemophilic factor B, or a combination.
PG, prostaglandin. This can be any or a combination of the following: misoprostol, sulprostone, dinoprostone, carboprost.
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syndrome and another had a previous manual removal of 
the placenta. Nine women delivered in a maternity unit 
with IR service availability (24/7 n=7, not 24/7 n=2) and 
four delivered in a non-IR unit. The mode of delivery in 
those 13 women who had no antenatal suspicion of AIP 
was elective CD in two women, emergency CD in five 
women and vaginal delivery in six women.
The placenta was left in situ in 11 women with AIP: four 
in an emergency setting where three women underwent 
immediate hysterectomy and one woman underwent 
urgent arterial embolisation followed by urgent hyster-
ectomy because of bleeding after 3 days. Another seven 
women had their placenta left in situ electively combined 
with planned IR: two women consecutively underwent 
planned hysterectomy, two an urgent hysterectomy within 
24 hours, two a planned hysterectomy after 1 month, and 
one elective evacuation of retained products of concep-
tion after 1 month. In conclusion, conservative manage-
ment, defined as aiming to preserve the placenta and the 
uterus in a multidisciplinary approach, was attempted in 
six women and was successful in three women.
As anticipated, the women for whom measures were 
planned antenatally had significantly better outcomes than 
those where AIP was diagnosed peripartum: less estimated 
blood loss (median 625 mL (range 300–1250) vs median 
4500 mL (range 500–6000), p=0.08), less need for trans-
fusion (46.2% vs 92.3%, p=0.056), less need for massive 
transfusion (≥8 units) (8.3% vs 53.8%, p=0.045) and fewer 
hysterectomies (61.5% vs 76.9%, p=0.6). The maternal 
outcome was not significantly different between women 
with AIP undergoing IR as first intervention and those with 
hysterectomy as first intervention: estimated blood loss 
(median 4000 mL (range 500–15000) vs median 1000 mL 
(range 300–8500), p=0.3), need for transfusion (76.5% vs 
70%, p=0.9) and need for massive transfusion (≥8 units) 
(29.4% vs 30%, p=1.0). All women with planned interven-
tions were managed in tertiary referral centres.
risk factors possibly contributing to the choice of intervention
The decision of an obstetrician dealing with a major 
obstetric haemorrhage to attempt IR rather than turning 
to a hysterectomy immediately will be guided by many 
clinical and organisational factors. Some of the risk 
factors that may have contributed to this decision are 
presented in table 3. The women with double interven-
tions (n=20) were excluded from this analysis to facilitate 
interpretation.
High parity (≥3), previous CD, CD in the index preg-
nancy, AIP and lack of emergency IR service availability are 
significantly positively associated with peripartum hysterec-
tomy in univariate analysis. In unconditional binary logistic 
regression, the odds of undergoing a hysterectomy for 
obstetric haemorrhage are 7.2 times higher in women with 
high parity and 8.2 times higher in women delivering in a 
non-IR unit, independent of the other risk factors in the 
model (Hosmer and Lemeshow test p=0.67).
We repeated the analysis in a subgroup, namely the 
women who delivered in a 24/7-IR unit, with exclusion 
of the women with planned interventions, consisting of 
31 women who underwent hysterectomy only and 60 
women who underwent embolisation only. In uncondi-
tional binary logistic regression, the odds of undergoing 
a peripartum hysterectomy for obstetric haemorrhage 
Figure 4 Antenatal suspicion and preventive measures in women with AIP. AIP, abnormally invasive placenta; FFP, fresh frozen 
plasma; IR, interventional radiology; RBC, red blood cells.
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are significantly higher in women with high parity (odds 
4.5 (95% CI 1.2 to 16.5)) and nearly significantly higher 
in women with previous CD (odds 3.7 (95% CI 0.98 to 
14.6)), independent of the other risk factors in the model 
(Hosmer and Lemeshow test p=0.69).
Peripartum hysterectomy despite Ir
Seventeen women in this data set had a peripartum hyster-
ectomy performed following a previous IR procedure. 
In five of these women the hysterectomy was performed 
in a programmed setting following planned IR because 
of AIP, two of them with a delay of 1 month. These five 
IR procedures were considered successful in preventing 
or stopping the bleeding. In the other 12 women, an 
urgent hysterectomy was performed because of persistent 
bleeding despite the IR procedure. We compared the 
characteristics of these 12 women for whom IR failed with 
87 women (including the 5 who underwent an elective 
hysterectomy) for whom IR was successful. In univariate 
analysis, an increased risk of urgent hysterectomy despite 
IR was observed for women with CD in a previous preg-
nancy, for women with AIP and for women who had 
no uterotonic agents administered. These findings are 
presented in table 4.
Maternal outcome and additional morbidity
Blood transfusion was given to 139 women (83.7%, 
missing data for 2 women), with a median of 6.0 units of 
RBCs (range 0–31), 4.0 units of FFP (range 0–31) and 0.5 
units of platelets (range 0–29). Fifty-one women (30.7%) 
were transfused ≥8 units of RBC and 23 women were 
administered clotting factors (fibrinogen, recombinant 
factor VIIa, prothrombin-proconvertin-Stuart factor-anti-
haemophilic factor B or a combination). One hundred 
and fourteen women (68.6%, missing data in 4 women) 
were admitted to an ICU for a median of 2.0 days (range 
0–18 days); the median hospital stay was 8.0 days (range 
2–33 days). Five women needed relaparotomy and three 
women needed arterial embolisation following hysterec-
tomy because of persistent bleeding. The cause of haem-
orrhage in these women was AIP (n=1), AIP and atony 
(n=2), atony (n=3) and in 1 case unclear (n=1).
DIC secondary to major haemorrhage was reported 
in 32 women (19%). Other reported maternal compli-
cations associated with major haemorrhage were renal 
failure (n=2), pulmonary oedema (n=4), acute respiratory 
distress syndrome (n=2), myocardial ischaemia (n=1) and 
pleural and pericardial effusion (n=1). Complications 
associated with peripartum hysterectomy were ureteral 
Table 3 Risk factors possibly contributing to the choice of intervention in women undergoing hysterectomy or interventional 
radiology for obstetric haemorrhage, unadjusted and adjusted OR (95% CI) for hysterectomy (only) per risk factor
Risk factors
Number of women Unadjusted OR 
(95% CI) for 
hysterectomy only
Adjusted OR 
(95% CI) for 
hysterectomy only
Hysterectomy 
only, n=64 n, %
Interventional radiology 
only, n=82 n, %
Demographic factors
  Maternal age ≥35 years 32 (50.0) 30 (36.5) 1.7 (0.8 to 3.3)
  Body mass index at booking 
≥30 kg/m2¶
6 (9.3) 3 (3.6) 2.7 (0.6 to 11.3)
Obstetric factors
  Preterm (<37 weeks) 28 (43.8) 24 (29.3) 1.8 (0.9 to 3.7)
  Parity ≥3 18 (28.1) 7 (8.5) 2.7 (1.4 to 9.4)§ 7.2 (2.1 to 24.6)§
  Previous caesarean delivery¶ 31 (48.4) 18 (21.9) 3.3 (1.6 to 6.8)§ 2.3 (0.9 to 6.3)
  Caesarean delivery (≥22 weeks)*¶ 38/59 (64.4) 37/82 (45.1) 2.2 (1.1 to 4.3)§ 1.6 (0.6 to 4.0)
Cause of bleeding
  AIP and AIP+praevia¶ 16 (25.0) 9 (10.9) 2.7 (1.1 to 6.6)§ 3.0 (0.9 to 10.0)
  Atony 29 (45.3) 52 (63.4) 0.4 (0.2 to 0.9)§ 0.9 (0.3 to 2.3)
Organisational factors
  Weekend and/or non-office 
hours†¶
24/60 (40.0) 34/80 (42.5) 0.9 (0.4 to 1.7)
  Interventional radiology NOT 
available‡
30 (46.8) 15 (18.2) 3.9 (1.8 to 8.2)§ 8.2 (3.1 to 21.6)§
*Exclusion of 5 cases<22 weeks.
†Based on date and time of delivery.
‡Emergency interventional radiology service availability in the maternity unit where the woman gave birth.
§p<0.05.
¶Missing data: body mass index (n=27), previous caesarean delivery (n=1), delivery mode (n=1), placenta location (n=13), date of delivery 
(n=2), time of delivery (n=5), week/weekend (n=3).
AIP, abnormally invasive placenta.
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injuries (n=2) and ileus (n=4). One woman suffered from 
pain in the loins and legs, which was the only reported 
complication attributed to the IR procedure.
One mother died (case fatality rate 0.6% (95% CI 0.1 
to 3.3)). She underwent an emergency CD because of 
cardiac arrest caused by massive pulmonary embolism. 
She survived the hysterectomy performed because of 
major bleeding due to uterine atony and was transferred 
to the ICU of a tertiary referral centre using extracorpo-
real life support. She underwent a relaparotomy because 
of major hepatic haemorrhage, but died the subsequent 
day during pulmonary thrombectomy.
Considering the whole group, the outcome in terms 
of transfusion rate and ICU admission in women who 
underwent hysterectomy did not significantly differ 
from those who underwent IR, except for a significant 
difference in total duration of hospitalisation (median 
9 days, range (2–30) vs median 7 days (range 2–33)). 
When comparing the women according to the IR 
service availability in the maternity unit where they gave 
birth, the rate of peripartum hysterectomy was signifi-
cantly higher in the group of women who delivered in a 
non-IR unit (29 women (74%)) than in the group who 
delivered in a 24/7-IR unit (44 women, 41%), and so 
was the rate of massive transfusion (defined as ≥8 units 
of RBC): 17 women (45%) who delivered in a non-IR 
unit compared with 25 women (24%) who delivered in 
a 24/7-IR unit.
Table 4 Risk factors possibly contributing to failure of IR, unadjusted ORs (95% CI) for failed IR per risk factor
Risk factors
Number of women Unadjusted OR 
(95% CI) for failed IRFailed IR, n=12 n, % Successful IR, n=87 n, %
Demographic factors
  Maternal age ≥35 years 5 (41.7) 33 (37.9) 1.1 (0.3 to 3.9)
  BMI at booking ≥30 kg/m2 2 (18.2)  3 (3.9) 5.6 (0.8 to 37.6)
Obstetric factors
  Twins 1 (8.3)  6 (6.9) 1.2 (0.1 to 11.1)
  Preterm gestational age <37 weeks
  Preterm gestational age <34 weeks
7 (58.3)
3 (25.0)
28 (32.2)
 6 (6.8)
2.9 (0.8 to 10.1)
4.5 (0.9 to 21.1)
  Parity ≥3 3 (25.0)  8 (9.2) 3.2 (0.7 to14.6)
  Previous caesarean delivery 7 (58.3) 21 (24.1) 4.4 (1.2 to 15.3)*
  Caesarean delivery (≥22 weeks) 8 (72.7) 42 (48.3) 2.1 (0.6 to 7.6)
  Induction of labour
  Augmentation of labour
3 (25.0)
2 (16.7)
25 (28.7)
26 (29.9)
0.8 (0.2 to 3.3)
0. (0.09 to 2.2)
Cause of haemorrhage
  Atony 7 (63.6) 52 (62.7) 0.9 (0.2 to 3.2)
  AIP and AIP+praevia 7 (58.3) 14 (16.1) 7.3 (2.0 to 26.3)*
  Surgical trauma 2 (16.7)  6 (6.9) 2.7 (0.4 to 15.2)
  Genital tract laceration 1 (8.3) 10 (11.5) 0.7 (0.08 to 6.0)
First-line and second-line treatment
  Uterotonic agents 8 (66.7) 82 (94.3) 0.1 (0.02 to 0.5)*
  No use of uterotonic agents 4 (33.3)  5 (5.7) 8.2 (1.8 to 36.8)*
  Intra-uterine balloon 3 (25.0) 26 (29.9) 0.7 (0.1 to 3.1)
  Clotting factors IV 2 (16.7)  8 (9.2) 1.9 (0.3 to 10.6)
  FFP 7 (58.3) 54 (62.1) 0.8 (0.2 to 2.9)
Organisational factors
  Planned intervention 2 (14) 10 (12) 1.5 (0.3 to 8.0)
  Weekend and/or non-office hours† 5/10 (50.0) 51/85 (60.0) 0.6 (0.1 to 2.4)
  IR NOT available‡ 3 (25.0) 10 (11.4) 2.5 (0.6 to 11.1)
  Emergency IR NOT available‡ 6 (50.0) 20 (22.9) 3.3 (0.9 to 11.5)
  Postnatal transfer 3 (25.0) 13 (14.9) 1.9 (0.4 to 7.9)
*p<0.05.
†Based on date and time of delivery.
‡IR service availability (24/7 and not 24/7) in the maternity unit where the woman gave birth.
‡Emergency IR service availability (24/7) in the maternity unit where the woman gave birth.
AIP, abnormally invasive placenta; BMI, body mass index; FFP, fresh frozen plasma; IR, interventional radiology.
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When comparing the women who gave birth in a non-IR 
unit according to whether they were transferred post-
partum, there was no significant difference in estimated 
blood loss (median 2850 mL (range 500–5000) vs median 
3500 mL (range 3000–5000), p=0.4) and need for trans-
fusion (median number of units 6.5 (range 0–19) vs 9.5 
(range 0–31), p=0.2), but all women who were not trans-
ferred (n=25/25) underwent a hysterectomy compared 
with 28% (n=4/14) in the transferred group (p=0.0).
DIsCussIOn
The main findings of this study are, first, that the prev-
alence in Belgium of major obstetric haemorrhage 
requiring peripartum hysterectomy and/or IR is esti-
mated at 6.6 (95% CI 5.7 to 7.7) per 10 000 deliveries; 
second, that AIP was not detected antenatally in 34% of 
the cases in this study, despite the presence of risk factors; 
third, that women with major obstetric haemorrhage who 
gave birth in a non-IR unit were more likely to undergo 
an urgent peripartum hysterectomy (74%) than those 
who delivered in a 24/7-IR unit (41%); and fourth, that 
the need for urgent peripartum hysterectomy was averted 
in 72% of the women who delivered in a non-IR unit but 
transferred postnatally, with no significant difference in 
estimated blood loss and transfusion rate compared with 
the women who were not transferred.
The strengths of the study are its methodology of 
collecting cases prospectively on a monthly basis and its 
national design, with excellent participation and response 
rates (98.9%) of Belgian maternity units. Under-reporting 
of cases, due to the non-mandatory reporting of severe 
pregnancy complications, may have biased our results 
to some extent. The small number of cases, inevitable 
with rare but severe obstetric complications, warrants 
caution in making strong inferences. Another limita-
tion is the lack of a perspective on the overall picture of 
postpartum haemorrhage in Belgium. We have no accu-
rate data of the total number of women suffering severe 
postpartum haemorrhage, the near-misses and maternal 
deaths due to severe haemorrhage who did not undergo 
embolisation or hysterectomy. We have no denominator 
data of the women who were successfully managed with 
other second-line measures (intra-uterine (balloon) 
tamponade, haemostatic brace suturing and ligation of 
the uterine arteries) during the same study period in 
Belgium, so we cannot draw conclusions on the failure 
rate of these second-line measures. These are interesting 
topics that can be investigated by B.OSS in future studies.
This nationwide population-based study describes how 
women with major obstetric haemorrhage were managed 
with either hysterectomy or IR according to circumstances. 
However, this study does not allow firm conclusions to be 
drawn regarding the motivation or the appropriateness 
of this management. One should be aware that obstetri-
cians are forced to make rapid decisions when dealing 
with a major obstetric haemorrhage. Belgian obstetri-
cians cannot rely on national guidelines for postpartum 
haemorrhage or AIP. Small volume maternity units even 
lack local hospital guidelines for these matters. There-
fore, the management of major obstetric haemorrhage 
will differ greatly between hospitals and individual obste-
tricians. An emergency IR service is available in about 
38% of Belgian maternity units, complemented with an 
informal network between hospitals as shown in the data 
set: 20 women (12%) were transferred to a centre with 
IR availability. We cannot rule out the possibility that 
this study in fact demonstrates an overuse of IR proce-
dures and underuse of other second-line measures in the 
management of postpartum haemorrhage in Belgium. 
This reasonable hypothesis has been previously suggested 
by Kayem et al22 based on the results of a population-based 
study of women with postpartum haemorrhage managed 
with invasive therapies in France.
The use of peripartum hysterectomy was significantly 
higher in multiparous women (parity ≥3) and in women 
who delivered in a non-IR unit. This result may not 
surprise, and performing a hysterectomy sooner rather 
than later must be considered good practice,6 as losing 
time trying another second-line measure can cause 
further blood loss and further morbidity. The decision 
is more easily made in cases of women who have no 
desire for continued fertility. Likewise, the transfer of a 
haemodynamically unstable patient to an IR service is 
hardly ever considered a safe alternative if this IR service 
is located in a nearby hospital. However, the higher rate 
of massive blood transfusion in the group of women 
who delivered in a non-IR unit strengthens the hypoth-
esis that the rate of hysterectomy is associated with the 
IR service availability and with the expert knowledge and 
experience at larger units in the management of massive 
obstetric haemorrhage. A case-by-case in-depth analysis 
would be necessary to reveal whether the hysterectomies 
and arterial embolisations recorded in this study were 
appropriate or preventable. A structured audit based on 
medical records of 50 peripartum hysterectomies was 
recently performed in Denmark. This population-based 
audit revealed that more than 50% of peripartum hyster-
ectomies were avoidable by simple measures such as the 
use of intrauterine balloons.23
AIP accounts for 23% of the interventions and 86% of 
the planned interventions in this data set. Targeted papers 
report good sensitivity and positive predictive value (PPV) 
of greyscale ultrasound as the screening tool for AIP in 
women with a high index of suspicion, enhanced by the use 
of transvaginal ultrasound and colour Doppler.24 25 None-
theless, the diagnosis of AIP was missed antenatally in 34% 
of the women in this study, although all of them had risk 
factors that should have increased awareness. Several popu-
lation-based studies report rather low antenatal diagnosis 
rates of AIP: 50% of AIP cases were missed in a study of 
the UK Obstetric Surveillance System, even though 30% 
of these missed cases had a previous CD and placenta 
praevia.26 Similarly, in the Nordic Obstetric Surveillance 
Study, 70% of AIP cases were missed, despite the fact that 
33% had placenta praevia and 39% had previous CD.27 In 
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view of these findings, we believe that antenatal diagnosis of 
AIP may be improved by raising the awareness of clinicians 
of the risk factors for AIP. This involves actively asking for 
previous uterine surgery at the first antenatal visit, checking 
the position of the placenta and focused imaging in the 
pregnancies at risk.28 Importantly, there is little information 
about the sensitivity or PPV of ultrasound or MRI as the 
screening tool for AIP in women who have had no previous 
uterine surgery or in women in whom the placenta is not 
implanted anteriorly in the lower uterine segment,24 which 
would be an interesting topic for future research. Despite 
increased awareness a number of cases of abnormal placen-
tation will still be missed. For this reason, all maternity units 
should ensure a state of constant preparedness to deal with 
an unanticipated AIP, which causes a major haemorrhage 
at any time.
Although numbers are small, this study aligns with 
the findings in previous studies that maternal outcome 
is better when women with suspicion of AIP give birth in 
specialised tertiary centres and when preventive measures 
are taken.26 29 30 A planned preterm caesarean hysterec-
tomy with the placenta left in situ is the indubitable treat-
ment of choice in women with AIP and is incorporated in 
recommendations of the Royal College of Obstetricians 
and Gynaecologists (RCOG),14 the American College of 
Obstetricians and Gynecologists (ACOG)31 and the Society 
for Maternal-Fetal Medicine (SMFM).32 Alternatively, a 
conservative approach is advocated for women who want 
to preserve their fertility and are haemodynamically stable, 
which means a multidisciplinary approach aiming to leave 
the placenta in situ and to preserve the uterus.33 34 This study 
demonstrates that conservative management of AIP is not 
well incorporated in obstetric care in Belgium. The placenta 
was left in situ in 11 women with AIP (29%) in this data set. 
A conservative approach was attempted in six women and 
was successful in three women. Two of these women under-
went a planned hysterectomy delayed until 1 month after 
the CD. A small number of papers support this manage-
ment (leaving the placenta in situ with a planned delayed 
hysterectomy) in women who have a placenta percreta with 
infiltration in the bladder and/or other surrounding tissues 
and therefore a high risk of haemorrhage or adjacent tissue 
injury,34–36 the rationale being that this delay will allow the 
decrease of the periuterine vascularisation and thus prevent 
haemorrhage. Studies with larger numbers are needed to 
strengthen evidence for the claim that this methodology 
is safer than caesarean hysterectomy in women with severe 
placenta percreta.
The role of IR in the management of AIP is still a 
matter of debate. Most guidelines agree that IR can be 
life-saving in the treatment of major postpartum haemor-
rhage.14 32 They currently do not recommend the routine 
use of preoperative placement of intra-arterial catheters to 
enable balloon occlusion or arterial embolisation before 
caesarean hysterectomy or conservative treatment of AIP, 
based on lack of evidence of benefit.14 31 32 37 Meanwhile, 
the number of papers reporting benefit of prophylactic 
IR is growing.38 39 Our population-based study reports 
diverse management of women with AIP, inherent to a 
multicentre study. Twelve women with AIP were managed 
with programmed IR, the need for hysterectomy being 
averted in six of them. We cannot draw firm conclusions 
on the success rate of IR in the elective setting because of 
small numbers and lack of controls.
This study has demonstrated a high success rate (87.8%) 
of IR in controlling postpartum haemorrhage, consistent 
with the success rates ranging between 85% and 95% 
reported by others.9–12 40–42 Univariate analysis (taking into 
account the small numbers) showed IR was more likely to 
fail in women with a CD in a previous pregnancy (failure 
rate 25%), women with AIP (33%) and women who had no 
uterotonic agents administered (44%). Several large, hospi-
tal-based, retrospective studies have analysed the predictive 
factors associated with failure of IR in the management of 
postpartum haemorrhage.12 40–43 Most papers report a lower 
success rate of IR in women with AIP,40 41 which explains to a 
great extent the lower success rates in women with previous 
CD and in women with CD in the current pregnancy. A 
population-based study in the Netherlands10 reported a 
25% failure rate for IR following CD in the current preg-
nancy, compared with just 16% in this study and barely 
10% in a large study reported by Lee et al (n=176).44 Other 
researchers have consistently reported a higher failure 
rate of IR in women with various clinical determinants 
related to major haemorrhage: haemodynamic shock,43 45 
diffuse intravascular coagulopathy,12 45 low fibrinogen and 
prothrombin time,41 and the need for massive transfu-
sion.12 40 41 However, these factors could be either cause 
or consequence of the failure of IR, which was not clearly 
differentiated in some of the aforementioned studies. Inter-
estingly, hospital-to-hospital transfer was not associated with 
a higher failure rate of IR in this study, consistent with what 
has been reported by others.12 40 41
COnClusIOn
The prevalence in Belgium of major obstetric haemorrhage 
requiring peripartum hysterectomy and/or IR is estimated 
at 6.6 (95% CI 5.7 to 7.7) per 10 000 deliveries: roughly 
1 in 3030 women who give birth in Belgium undergoes a 
peripartum hysterectomy, while another 1 in 3030 women is 
successfully managed by IR, thereby preserving the uterus. 
Abnormal placentation and/or uterine atony are reported 
as the cause of haemorrhage and reason for intervention 
in the majority of these women (83.7%). Further improve-
ment in the management of obstetric haemorrhage could 
possibly be achieved by increased awareness of risk factors 
for abnormal placentation on the part of clinicians and by 
antenatal transfer to tertiary centres in case of suspicion. A 
case-by-case in-depth analysis is necessary to reveal whether 
the hysterectomies and arterial embolisations performed in 
this study were appropriate or preventable.
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